These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 7511052

  • 21. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.
    Cancer Res; 1997 Jun 01; 57(11):2256-67. PubMed ID: 9187130
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J, Flanagan J, Phillips WA, Chenevix-Trench G, Arnold J.
    Br J Cancer; 2003 Jan 27; 88(2):270-6. PubMed ID: 12610513
    [Abstract] [Full Text] [Related]

  • 27. Absence of ST7 gene alterations in human cancer.
    Dong SM, Sidransky D.
    Clin Cancer Res; 2002 Sep 27; 8(9):2939-41. PubMed ID: 12231539
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Absence of prohibitin gene mutations in human epithelial ovarian tumors.
    Cliby W, Sarkar G, Ritland SR, Hartmann L, Podratz KC, Jenkins RB.
    Gynecol Oncol; 1993 Jul 27; 50(1):34-7. PubMed ID: 8349162
    [Abstract] [Full Text] [Related]

  • 30. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 27; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 31. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.
    Vorechovský I, Tingby O, Hartman M, Strömberg B, Nister M, Collins VP, Toftgård R.
    Oncogene; 1997 Jul 17; 15(3):361-6. PubMed ID: 9233770
    [Abstract] [Full Text] [Related]

  • 32. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
    Palanca Suela S, Esteban Cardeñosa E, Barragán González E, Oltra Soler S, de Juan Jiménez I, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Bolufer Gilabert P, Group for Assessment of Hereditary Cancer of Valencia Community.
    Breast Cancer Res Treat; 2008 Nov 17; 112(1):63-7. PubMed ID: 18060491
    [Abstract] [Full Text] [Related]

  • 33. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families.
    Montagna M, Santacatterina M, Torri A, Menin C, Zullato D, Chieco-Bianchi L, D'Andrea E.
    Oncogene; 1999 Jul 15; 18(28):4160-5. PubMed ID: 10435598
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene.
    Sekido Y, Ahmadian M, Wistuba II, Latif F, Bader S, Wei MH, Duh FM, Gazdar AF, Lerman MI, Minna JD.
    Oncogene; 1998 Jun 18; 16(24):3151-7. PubMed ID: 9671394
    [Abstract] [Full Text] [Related]

  • 36. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer.
    Sato T, Saito H, Swensen J, Olifant A, Wood C, Danner D, Sakamoto T, Takita K, Kasumi F, Miki Y.
    Cancer Res; 1992 Mar 15; 52(6):1643-6. PubMed ID: 1540973
    [Abstract] [Full Text] [Related]

  • 37. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
    Prosser J, Thompson AM, Cranston G, Evans HJ.
    Oncogene; 1990 Oct 15; 5(10):1573-9. PubMed ID: 2250913
    [Abstract] [Full Text] [Related]

  • 38. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
    Yamada Y, Yoshida T, Hayashi K, Sekiya T, Yokota J, Hirohashi S, Nakatani K, Nakano H, Sugimura T, Terada M.
    Cancer Res; 1991 Nov 01; 51(21):5800-5. PubMed ID: 1933850
    [Abstract] [Full Text] [Related]

  • 39. Defining a common region of deletion at 13q21 in human cancers.
    Chen C, Brabham WW, Stultz BG, Frierson HF, Barrett JC, Sawyers CL, Isaacs JT, Dong JT.
    Genes Chromosomes Cancer; 2001 Aug 01; 31(4):333-44. PubMed ID: 11433524
    [Abstract] [Full Text] [Related]

  • 40. Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
    Brenner AJ, Paladugu A, Wang H, Olopade OI, Dreyling MH, Aldaz CM.
    Clin Cancer Res; 1996 Dec 01; 2(12):1993-8. PubMed ID: 9816158
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.